420 with CNW — Commissioner Califf Admits FDA Hasn’t Done Much on CBD
While addressing a Congressional panel, FDA chief Dr. Robert Califf admitted that the agency he heads hasn’t been as fast as stakeholders may want as it handles matters of creating regulatory pathways for different products, including cannabidiol, extracted from hemp. This is despite the legalization at a federal level of hemp as well as its derivatives several years ago. He admitted that while things look the same as they were when hemp was legalized back in 2018, his agency now has more data because it has been doing plenty of research. He added that most of the funds allocated to…

















